206 related articles for article (PubMed ID: 38807172)
1. Blood metabolites and chronic kidney disease: a Mendelian randomization study.
Hou Y; Xiao Z; Zhu Y; Li Y; Liu Q; Wang Z
BMC Med Genomics; 2024 May; 17(1):147. PubMed ID: 38807172
[TBL] [Abstract][Full Text] [Related]
2. Causal Effects of Specific Gut Microbiota on Chronic Kidney Diseases and Renal Function-A Two-Sample Mendelian Randomization Study.
Li N; Wang Y; Wei P; Min Y; Yu M; Zhou G; Yuan G; Sun J; Dai H; Zhou E; He W; Sheng M; Gao K; Zheng M; Sun W; Zhou D; Zhang L
Nutrients; 2023 Jan; 15(2):. PubMed ID: 36678231
[TBL] [Abstract][Full Text] [Related]
3. Causal effects of human serum metabolites on occurrence and progress indicators of chronic kidney disease: a two-sample Mendelian randomization study.
Yin Y; Shan C; Han Q; Chen C; Wang Z; Huang Z; Chen H; Sun L; Fei S; Tao J; Han Z; Tan R; Gu M; Ju X
Front Nutr; 2023; 10():1274078. PubMed ID: 38260086
[TBL] [Abstract][Full Text] [Related]
4. Genetic association between celiac disease and chronic kidney disease: a two-sample Mendelian randomization study.
Chen Z; Zheng Z; Jiang B; Xu Y
Ren Fail; 2024 Dec; 46(2):2357246. PubMed ID: 38832490
[TBL] [Abstract][Full Text] [Related]
5. Causal effects of systemic inflammatory regulators on chronic kidney diseases and renal function: a bidirectional Mendelian randomization study.
Li H; Li M; Liu C; He P; Dong A; Dong S; Zhang M
Front Immunol; 2023; 14():1229636. PubMed ID: 37711613
[TBL] [Abstract][Full Text] [Related]
6. Non-targeted metabolomics revealed novel links between serum metabolites and primary ovarian insufficiency: a Mendelian randomization study.
Chen S; Zhou Z; Zhou Z; Liu Y; Sun S; Huang K; Yang Q; Guo Y
Front Endocrinol (Lausanne); 2024; 15():1307944. PubMed ID: 38737546
[TBL] [Abstract][Full Text] [Related]
7. Causality of genetically determined metabolites on anxiety disorders: a two-sample Mendelian randomization study.
Xiao G; He Q; Liu L; Zhang T; Zhou M; Li X; Chen Y; Chen Y; Qin C
J Transl Med; 2022 Oct; 20(1):475. PubMed ID: 36266699
[TBL] [Abstract][Full Text] [Related]
8. Genetically determined blood lead is associated with reduced renal function amongst individuals with type 2 diabetes mellitus: insight from Mendelian Randomisation.
Mazidi M; Kirwan R; Davies IG
J Mol Med (Berl); 2022 Jan; 100(1):125-134. PubMed ID: 34661687
[TBL] [Abstract][Full Text] [Related]
9. Associations of systemic inflammatory regulators with CKD and kidney function: evidence from the bidirectional mendelian randomization study.
Liu H; Xiang W; Wu W; Zhou G; Yuan J
BMC Nephrol; 2024 May; 25(1):161. PubMed ID: 38730296
[TBL] [Abstract][Full Text] [Related]
10. The Effects of Specific Gut Microbiota and Metabolites on IgA Nephropathy-Based on Mendelian Randomization and Clinical Validation.
Wang F; Li N; Ni S; Min Y; Wei K; Sun H; Fu Y; Liu Y; Lv D
Nutrients; 2023 May; 15(10):. PubMed ID: 37242290
[TBL] [Abstract][Full Text] [Related]
11. Effects of Metabolic Syndrome and Its Components on Chronic Kidney Disease and Renal Function: A Two-Sample Mendelian Randomization Study.
Yang H; Cui Z; Quan Z
Metab Syndr Relat Disord; 2024 Mar; 22(2):114-122. PubMed ID: 37944108
[No Abstract] [Full Text] [Related]
12. Metabolome-wide Mendelian randomization reveals causal effects of betaine and N-acetylornithine on impairment of renal function.
Liu Y; Ling L; Shen Y; Bi X
Front Nutr; 2024; 11():1371995. PubMed ID: 38721027
[TBL] [Abstract][Full Text] [Related]
13. Causal relationship between gut microbiota and kidney diseases: a two-sample Mendelian randomization study.
Feng Z; Zhang Y; Lai Y; Jia C; Wu F; Chen D
Front Immunol; 2023; 14():1277554. PubMed ID: 38283353
[TBL] [Abstract][Full Text] [Related]
14. Causal effects of gut microbiota on the risk of chronic kidney disease: a Mendelian randomization study.
Luo M; Cai J; Luo S; Hong X; Xu L; Lin H; Chen X; Fu W
Front Cell Infect Microbiol; 2023; 13():1142140. PubMed ID: 37065213
[TBL] [Abstract][Full Text] [Related]
15. Exploring blood metabolites and thyroid disorders: a bidirectional mendelian randomization study.
Zhang X; Zhou J; Xie Z; Li X; Hu J; He H; Li Z
Front Endocrinol (Lausanne); 2023; 14():1270336. PubMed ID: 37876541
[TBL] [Abstract][Full Text] [Related]
16. Genetic evidence supporting the causal role of gut microbiota in chronic kidney disease and chronic systemic inflammation in CKD: a bilateral two-sample Mendelian randomization study.
Ren F; Jin Q; Jin Q; Qian Y; Ren X; Liu T; Zhan Y
Front Immunol; 2023; 14():1287698. PubMed ID: 38022507
[TBL] [Abstract][Full Text] [Related]
17. The causal relationship between blood metabolites and rosacea: A Mendelian randomization.
Yao H; Shen S; Gao X; Song X; Xiang W
Skin Res Technol; 2024 Jun; 30(6):e13796. PubMed ID: 38895784
[TBL] [Abstract][Full Text] [Related]
18. Causal relationship between basal metabolic rate and kidney function: a bidirectional two-sample mendelian randomization study.
Zhou C; Peng Y; Zhan L; Zha Y
Front Endocrinol (Lausanne); 2024; 15():1319753. PubMed ID: 38726345
[TBL] [Abstract][Full Text] [Related]
19. Adverse Impact of
Mazidi M; Shekoohi N; Covic A; Mikhailidis DP; Banach M
Nutrients; 2020 Jul; 12(8):. PubMed ID: 32722370
[TBL] [Abstract][Full Text] [Related]
20. Higher Plasma Levels of Valerate Produced by Gut Microbiota May Have a Beneficial Impact on Renal Function.
Mazidi M; Katsiki N; Banach M
J Am Nutr Assoc; 2023 Aug; 42(6):534-540. PubMed ID: 36786830
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
